Why is ZNTL Down Today?
About Zentalis Pharmaceuticals, Inc. Common Stock
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a s...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
Quick Trade Ideas
Options strategies to consider for ZNTL's -6% move
No Options Available
ZNTL doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get ZNTL Alerts
We'll notify you when ZNTL's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
ZNTL has moved more than 3.0% down on 61 occasions in the past year.
Frequently Asked Questions
Why is ZNTL stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is ZNTL stock a buy or sell right now?
Based on current analysis, ZNTL shows 67% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the ZNTL stock price target?
ZNTL is currently trading at $2.60. Based on today's momentum, the expected short-term range is $2.52 - $2.65. See long-term price prediction →
Will ZNTL stock continue falling?
Our analysis shows a 45% probability that ZNTL's move continues in the next 1-3 days. Key level to watch: $2.47 (support).
Is ZNTL stock oversold or overbought?
ZNTL's RSI (Relative Strength Index) is currently at 28.2. This indicates oversold conditions - the stock may be due for a bounce as selling pressure appears exhausted.
What is the momentum for ZNTL stock?
ZNTL's 10-day momentum indicator is at -0.47. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is ZNTL outperforming or underperforming the market?
ZNTL (-6.32%) is currently significantly underperforming the market (-6.5% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for ZNTL?
ZNTL's MACD (-0.34) is currently below the signal line (-0.31), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 34.6) is strong.
Is ZNTL in an uptrend or downtrend?
Based on moving average analysis, ZNTL is in a bearish trend. The price ($2.60) is trading below both the 20-day SMA ($3.2) and 50-day SMA ($3.79). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis